Brief: Immunovia Enters Licensing Agreement With JW BioScience For Pancreatic Cancer Biomarkers

Immunovia AB (publ)

13/09/2021 10:01

Sept 13 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * IMMUNOVIA ENTERS LICENSING AGREEMENT WITH JW BIOSCIENCE
FOR
PANCREATIC CANCER BIOMARKERS
    * AGREEMENT GIVES IMMUNOVIA GLOBAL COMMERCIAL RIGHTS FOR TWO
BIOMARKERS FOR EARLY DETECTION OF PANCREATIC CANCER
    * DETAILS AND DEAL SIZE OF THIS CONTRACT ARE NOT DISCLOSED
AS
AGREED BY BOTH PARTIES
    * OBTAINS A GLOBAL LICENSE FROM SOUTH KOREAN COMPANY JW
BIOSCIENCE'S IP PORTFOLIO

Source text for Eikon:  ID:nWkr6D3HzF 
Further company coverage:  IMMNOV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))